Master complexity across a global portfolio
When you manage dozens of products across global markets, with even more products in the pipeline, you need a solution that scales with your business. Dr.Evidence provides an Authoritative Source that is fast, efficient, and comprehensive. Your teams gain hours back each week, and can make decisions backed by comprehensive landscape intelligence, not guesswork.
your strategy with current and accurate evidence–driven insights from across the market landscape, including prior precedent and competitive intelligence.
strategic decision-making and time-to-market with specialized workflows and fit-for-purpose AI.
time-intensive, routine tasks so you operate strategically at the top of your capabilities.
by sharing insights across the enterprise, breaking down silos, and increasing collaboration with a single solution.
labels, drug applications, clinical trials and scientific literature into a unified workflow.
fragmented evidence from multiple sources into a clear decision pathway.
Harmonize global labeling strategies across therapeutic areas and geographies, identifying opportunities to streamline without compromising accuracy.
Streamline approvals with the ability to automate manual processes and rapidly and accurately incorporate prior precedent.
De-risk lifecycle management decisions with competitive intelligence that reveals how peers are navigating label expansions, safety updates, and indication changes.
Accelerate post-approval changes by instantly understanding regulatory precedent across markets.
Prepare for negotiations with health authorities and respond to regulatory inquiries.
Join the leading biopharma companies worldwide who've made Dr.Evidence their competitive advantage. Get the landscape intelligence platform that grows with you—from first submission to long-term commercial success.
Book a Demo